Breast Cancer Drug Set To Transform Prostate Cancer Treatment

A drug used to treat breast and ovarian cancer can extend the lives of some men with prostate cancer and should become a new standard treatment for the disease, concludes a major trial which is set to change clinical practice.

Final results from the trial showed that olaparib - a pioneering type of drug called a PARP inhibitor...